Media Summary: Joseph Eron, MD, professor of medicine at the University of North Carolina at Chapel Hill, explains Global HIV Clinical Forum 2016 Speaker: Mark Wainberg, MD For more medical education programs, as well as the latest ... Explore the The Structural Biology of HIV on PDB-101 ...

How Integrase Inhibitors Have Dramatically - Detailed Analysis & Overview

Joseph Eron, MD, professor of medicine at the University of North Carolina at Chapel Hill, explains Global HIV Clinical Forum 2016 Speaker: Mark Wainberg, MD For more medical education programs, as well as the latest ... Explore the The Structural Biology of HIV on PDB-101 ... Speaker: Ian Frank Presented at Session 1: Introduction to International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016 Speaker: Jonathan Schapiro, MD Presented at ... International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018 Speaker: Giovanni Di Perri, ...

Global Epidemics: What's Driving Discovery in HIV and TB? Daria Hazuda, Merck Research Laboratories "The Discovery and ... Speaker: David Back, PhD Presented at Session 2: Differences Between

Photo Gallery

How Integrase Inhibitors Have Dramatically Changed HIV Therapy
Basic Science of Integrase Inhibitors | Mark Wainberg, MD
HIV Integrase Action
The Integrase Inhibitors drug class: a comparative clinical review | Ian Frank
The role of integrase inhibitors in reducing immune activation
Resistance Characteristics of Integrase Inhibitors | Jonathan Schapiro, MD
HIV Reverse Transcriptase and Integrase Inhibitors: Screening
Integrase inhibitor resistance: does it matter? - Charles Boucher, MD, PhD
Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD
The Discovery and Development of Inhibitors of HIV-1 Integrase
Optimal Use of Integrase Inhibitors in Women | Sharon Walmsley, FRCPC, MD, MSC
Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | David Back, PhD
Sponsored
Sponsored
View Detailed Profile
How Integrase Inhibitors Have Dramatically Changed HIV Therapy

How Integrase Inhibitors Have Dramatically Changed HIV Therapy

Joseph Eron, MD, professor of medicine at the University of North Carolina at Chapel Hill, explains

Basic Science of Integrase Inhibitors | Mark Wainberg, MD

Basic Science of Integrase Inhibitors | Mark Wainberg, MD

Global HIV Clinical Forum 2016 Speaker: Mark Wainberg, MD For more medical education programs, as well as the latest ...

Sponsored
HIV Integrase Action

HIV Integrase Action

Explore the The Structural Biology of HIV on PDB-101 ...

The Integrase Inhibitors drug class: a comparative clinical review | Ian Frank

The Integrase Inhibitors drug class: a comparative clinical review | Ian Frank

Speaker: Ian Frank Presented at Session 1: Introduction to

The role of integrase inhibitors in reducing immune activation

The role of integrase inhibitors in reducing immune activation

Dr. Daniel Douek talks about the role of

Sponsored
Resistance Characteristics of Integrase Inhibitors | Jonathan Schapiro, MD

Resistance Characteristics of Integrase Inhibitors | Jonathan Schapiro, MD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016 Speaker: Jonathan Schapiro, MD Presented at ...

HIV Reverse Transcriptase and Integrase Inhibitors: Screening

HIV Reverse Transcriptase and Integrase Inhibitors: Screening

Watch the Full Video at ...

Integrase inhibitor resistance: does it matter? - Charles Boucher, MD, PhD

Integrase inhibitor resistance: does it matter? - Charles Boucher, MD, PhD

Session 1 -

Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD

Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018 Speaker: Giovanni Di Perri, ...

The Discovery and Development of Inhibitors of HIV-1 Integrase

The Discovery and Development of Inhibitors of HIV-1 Integrase

Global Epidemics: What's Driving Discovery in HIV and TB? Daria Hazuda, Merck Research Laboratories "The Discovery and ...

Optimal Use of Integrase Inhibitors in Women | Sharon Walmsley, FRCPC, MD, MSC

Optimal Use of Integrase Inhibitors in Women | Sharon Walmsley, FRCPC, MD, MSC

Lecture: Optimal Use of

Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | David Back, PhD

Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | David Back, PhD

Speaker: David Back, PhD Presented at Session 2: Differences Between

Resistance to Integrase Inhibitors | What Clinicians Need to Know | Roger Paredes, MD, PhD

Resistance to Integrase Inhibitors | What Clinicians Need to Know | Roger Paredes, MD, PhD

Lecture: Resistance to